Delivery Order SPE2DB24D2013-SPE2DB25FCGQM
Award Date
10/16/24
Potential Completion Date
10/17/24
Potential Value
$10K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The $12,871.11 firm-fixed-price contract is for the delivery of the diabetes medication Mounjaro (tirzepatide) 7.5 mg/0.5 ml pens. The contract has an ultimate completion date of April 24, 2025 and is not designated as a set-aside. AmerisourceBergen is a critical supplier of pharmaceutical products and medical supplies to various government...
This is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of the diabetes medication Mounjaro (tirzepatide) 7.5 mg/0.5 ml pens, with a ceiling value of $11,093.27 and a period of performance through April 16, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the diabetes medication Mounjaro (tirzepatide) 10 mg/0.5 ml pens. The contract has a ceiling value of $2,629.79 and a period of performance ending on May 1, 2025. It is a firm-fixed-price contract, without any set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of the diabetes medication Mounjaro (tirzepatide) 10 mg/0.5 mL pens. The contract has a firm fixed price of $1,632.54 and a period of performance ending on May 5, 2025. It is not a set-aside contract, indicating open competition. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the diabetes medication Mounjaro (Tirzepatide) 15 mg/0.5 ml pens. The contract has a firm fixed price of $4,590.11 and a period of performance through May 5, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which serves as a comprehensive...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $4,418.73, is for the supply of the diabetes medication Mounjaro (tirzepatide) 7.5 mg/0.5 mL pens. The contract has an ultimate completion date of April 17, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which serves...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the diabetes medication Mounjaro (Tirzepatide) 15 mg/0.5 ml pens. The contract has a firm fixed price, a ceiling value of $15,645.27, and an ultimate completion date of May 5, 2025. This contract is not set aside and represents an open competition award. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $29,500.48, is for the supply of the diabetes medication Mounjaro (tirzepatide) 7.5 mg/0.5 mL pens. The contract has a period of performance through May 1, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00,...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of the medication Mounjaro (tirzepatide) 7.5 mg/0.5 ml pens. The contract has a firm fixed price of $5,189.64 and a completion date of August 1, 2024. This is a delivery order contract, which is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025 between AmerisourceBergen and the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,251.06 Firm Fixed Price delivery order is for the supply of the diabetes medication Mounjaro (12.5 mg/0.5 ml pen, 0.5 ml) with a period of performance through May 9, 2025. AmerisourceBergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...